Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis

被引:76
作者
Fargnoli, M. C. [1 ]
Esposito, M. [43 ,1 ]
Ferrucci, S. [2 ]
Girolomoni, G. [3 ]
Offidani, A. [4 ]
Patrizi, A. [5 ]
Peris, K. [6 ,7 ]
Costanzo, A. [8 ,9 ]
Malara, G. [10 ]
Pellacani, G. [11 ]
Romanelli, M. [12 ]
Amerio, P. [13 ]
Cristaudo, A. [14 ]
Flori, M. L. [15 ]
Motolese, A. [16 ]
Betto, P. [17 ]
Patruno, C. [18 ]
Pigatto, P. [19 ]
Sirna, R. [20 ]
Stinco, G. [21 ]
Zalaudek, I. [22 ]
Bianchi, L. [23 ]
Boccaletti, V. [24 ]
Cannavo, S. P. [25 ]
Cusano, F. [26 ]
Lembo, S. [27 ]
Mozzillo, R. [28 ]
Gallo, R. [29 ]
Potenza, C. [30 ]
Rongioletti, F. [31 ]
Tiberio, R. [32 ]
Grieco, T. [33 ]
Micali, G. [34 ]
Persechino, S. [35 ]
Pettinato, M. [36 ]
Pucci, S. [37 ]
Savi, E. [38 ]
Stingeni, L. [39 ]
Romano, A. [40 ]
Argenziano, G. [41 ]
Calabrese, Giulia
Campanati, Anna
Caruso, Cristiano
Chello, Camilla
De Pasquale, Tiziana
Di Costanzo, Luisa
Dini, Valentina
De Pasquale, Rocco
Del Giglio, Micol
Fracassi, Giovanna
机构
[1] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dermatol Unit, Laquila, Italy
[2] Fdn IRCCS Ca Grande Osped Maggiore Policlin, Unit Dermatol, Milan, Italy
[3] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy
[4] Polytech Marche Univ, Dept Clin & Mol Sci, Dermatol Unit, Ancona, Italy
[5] Univ Bologna, Dept Expt Diagnost & Specialty Med, Dermatol Unit, Bologna, Italy
[6] Catholic Univ, Inst Dermatol, Rome, Italy
[7] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[8] Humanitas Univ, Dept Biomed Sci, Dermatol Unit, Rozzano, Italy
[9] Humanitas Clin & Res Ctr, Rozzano, Italy
[10] Grande Osped Metropolitano, Bianchi Melacrino Morelli, Dermatol Dept, Reggio Di Calabria, Italy
[11] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy
[12] Univ Pisa, Dept Clin & Expt Med, Dermatol Unit, Pisa, Italy
[13] Univ G dAnnunzio, Dermatol Clin, Dept Med & Aging Sci, Chieti, Italy
[14] San Gallicano Dermatol Inst IRCCS, Unit Dermatol, Rome, Italy
[15] Univ Siena, Hosp S Maria Scotte, Dept Clin Med & Immunol Sci, Dermatol Sect, Siena, Italy
[16] Macchi Hosp, Dept Dermatol, Varese, Italy
[17] ULSS8 Berica, Osped San Bortolo, Dept Dermatol, Vicenza, Italy
[18] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[19] Univ Milan, IRCCS Galeazzi Orthopaed Inst, Clin Dermatol, Dept Biomed Surg & Dent Sci, Milan, Italy
[20] Osped Misericordia, Unit Dermatol, Grosseto, Italy
[21] Univ Udine, Inst Dermatol, Dept Med, Udine, Italy
[22] Hosp Maggiore Trieste, Dermatol Clin, Trieste, Italy
[23] Univ Tor Vergata, Dept Dermatol, Rome, Italy
[24] Univ Hosp, Dept Clin & Expt Med, Sect Dermatol, Parma, Italy
[25] Univ Messina, Dept Clin & Expt Med, Dermatol, Messina, Italy
[26] Gaetano Rummo Hosp Benevento, Dermatol Unit, Benevento, Italy
[27] Univ Hosp San Giovanni Dio & Ruggi Salerno, Hosp Santa Maria Incoronata Olmo, Unit Dermatol, Salerno, Italy
[28] San Gennaro Hosp, Dermatol & Venereol, Naples, Italy
[29] Univ Genoa, Polyclin Hosp San Martino, Dept Hlth Sci, Dermatol Sect, Genoa, Italy
[30] Sapienza Univ Rome Polo Pontino, Dept Med & Surg Sci & Biotechnol, Dermatol Unit, Rome, Italy
[31] Univ Cagliari, Dept Med Sci & Publ Hlth, Sect Dermatol, Cagliari, Italy
[32] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy
[33] Sapienza Univ Rome, Dermatol Clin Umberto 1, Rome, Italy
[34] Univ Catania, Dermatol Clin, Catania, Italy
[35] Sapienza Univ Rome, NESMOS Dept, St Andrea Hosp, Dermatol Unit, Rome, Italy
[36] Policlin Vittorio Emanuele, Univ Hosp, Unit Dermatol, Catania, Italy
[37] Hosp Civitanova Marche, Allergol, Marche, Italy
[38] Hosp Guglielmo Saliceto, Unit Dermatol, Piacenza, Italy
[39] Univ Perugia, Dermatol Sect, Dept Med, Perugia, Italy
[40] Catholic Univ, Fdn Policlin Univ A Gemelli IRCCS, Columbus Presidium, Allergol Unit, Rome, Italy
[41] Univ Campania Luigi Vanvitelli, Dermatol Unit, Naples, Italy
关键词
Atopic dermatitis; dupilumab; real-life; ECZEMA; RELIABILITY; PLACEBO;
D O I
10.1080/09546634.2019.1682503
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Dupilumab, a fully human monoclonal antibody targeting the alpha subunit of IL-4 was recently approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients. Objective: To assess dupilumab effectiveness and safety in adults with moderate-to-severe AD in a real-life Italian multicentre retrospective cohort. Methods: Adult moderate-to-severe AD patients, referring to 39 Italian centers, received dupilumab in the context of a national patient access program. Disease assessment was performed at baseline, after 4 and 16 weeks of treatment using Eczema-Area-and-Severity-Index (EASI) score, itch and sleep numerical-rating-score (itch-NRS, sleep-NRS) and Dermatology-Life-Quality-Index (DLQI). Results: A total of 109 (71 M/38F) patients was studied. There was a significant reduction in EASI score, itch-NRS, sleep-NRS and DLQI from baseline to week 4 and a further significant decline to week 16. EASI 50, EASI75 and EASI90 were achieved by 59.6%, 28.4% and 9.3% of patients at 4 weeks and by 87.2%, 60.6% and 32.4% of them at 16 weeks, respectively. Adverse events were experienced by 19.2% (21/109) of the patients and they were all mild in intensity, being conjunctivitis the most common side effect. Conclusions: Dupilumab significantly improved disease severity, pruritus, sleep loss and quality of life with an acceptable safety profile.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 21 条
[1]   Conjunctivitis in dupilumab clinical trials [J].
Akinlade, B. ;
Guttman-Yassky, E. ;
de Bruin-Weller, M. ;
Simpson, E. L. ;
Blauvelt, A. ;
Cork, M. J. ;
Prens, E. ;
Asbell, P. ;
Akpek, E. ;
Corren, J. ;
Bachert, C. ;
Hirano, I. ;
Weyne, J. ;
Korotzer, A. ;
Chen, Z. ;
Hultsch, T. ;
Zhu, X. ;
Davis, J. D. ;
Mannent, L. ;
Hamilton, J. D. ;
Teper, A. ;
Staudinger, H. ;
Rizova, E. ;
Pirozzi, G. ;
Graham, N. M. H. ;
Shumel, B. ;
Ardeleanu, M. ;
Wollenberg, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) :459-473
[2]   Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy [J].
Ariens, Lieneke F. M. ;
Bakker, Daphne S. ;
van der Schaft, Jorien ;
Garritsen, Floor M. ;
Thijs, Judith L. ;
de Bruin-Weller, Marjolein S. .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (09) :159-170
[3]   Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series [J].
Armario-Hita, J. C. ;
Pereyra-Rodriguez, J. ;
Silvestre, J. F. ;
Ruiz-Villaverde, R. ;
Valero, A. ;
Izu-Belloso, R. ;
Jauregui-Presa, I. ;
Curto-Barredo, L. ;
Figueras-Nart, I. ;
Herranz-Pinto, P. ;
Herraez-Herrera, L. ;
Ortiz-de-Frutos, F. J. ;
Martinez-Pilar, L. ;
Sastre, J. ;
Serra-Baldrich, E. .
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (05) :1072-1074
[4]  
Badia X, 1999, BRIT J DERMATOL, V141, P698
[5]   Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis [J].
Beck, Lisa A. ;
Thaci, Diamant ;
Hamilton, Jennifer D. ;
Graham, Neil M. ;
Bieber, Thomas ;
Rocklin, Ross ;
Ming, Jeffrey E. ;
Ren, Haobo ;
Kao, Richard ;
Simpson, Eric ;
Ardeleanu, Marius ;
Weinstein, Steven P. ;
Pirozzi, Gianluca ;
Guttman-Yassky, Emma ;
Suarez-Farinas, Mayte ;
Hager, Melissa D. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Radin, Allen R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02) :130-139
[6]   Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial [J].
Blauvelt, Andrew ;
de Bruin-Weller, Marjolein ;
Gooderham, Melinda ;
Cather, Jennifer C. ;
Weisman, Jamie ;
Pariser, David ;
Simpson, Eric L. ;
Papp, Kim A. ;
Hong, H. Chih-Ho ;
Rubel, Diana ;
Foley, Peter ;
Prens, Errol ;
Griffiths, Christopher E. M. ;
Etoh, Takafumi ;
Pinto, Pedro Herranz ;
Pujol, Ramon M. ;
Szepietowski, Jacek C. ;
Ettler, Karel ;
Kemeny, Lajos ;
Zhu, Xiaoping ;
Akinlade, Bolanle ;
Hultsch, Thomas ;
Mastey, Vera ;
Gadkari, Abhijit ;
Eckert, Laurent ;
Amin, Nikhil ;
Graham, Neil M. H. ;
Pirozzi, Gianluca ;
Stahl, Neil ;
Yancopoulos, George D. ;
Shumel, Brad .
LANCET, 2017, 389 (10086) :2287-2303
[7]   Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE) [J].
de Bruin-Weller, M. ;
Thaci, D. ;
Smith, C. H. ;
Reich, K. ;
Cork, M. J. ;
Radin, A. ;
Zhang, Q. ;
Akinlade, B. ;
Gadkari, A. ;
Eckert, L. ;
Hultsch, T. ;
Chen, Z. ;
Pirozzi, G. ;
Graham, N. M. H. ;
Shumel, B. .
BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) :1083-1101
[8]   Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data [J].
de Wijs, L. E. M. ;
Bosma, A. L. ;
Erler, N. S. ;
Hollestein, L. M. ;
Gerbens, L. A. A. ;
Middelkamp-Hup, M. A. ;
Kunkeler, A. C. M. ;
Nijsten, T. E. C. ;
Spuls, P. I. ;
Hijnen, D. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (02) :418-426
[9]   Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort [J].
Faiz, Sarah ;
Giovannelli, Jonathan ;
Podevin, Celine ;
Jachiet, Marie ;
Bouaziz, Jean-David ;
Reguiai, Ziad ;
Nosbaum, Audrey ;
Lasek, Audrey ;
le Bouedec, Marie-Christine Ferrier ;
Aurelie Du Thah ;
Raison-Peyron, Nadia ;
Tetart, Florence ;
Duval-Modeste, Anne-Benedicte ;
Misery, Laurent ;
Aubin, Francois ;
Dompmartin, Anne ;
Morice, Cecile ;
Droitcourt, Catherine ;
Soria, Angele ;
Arnault, Jean-Philippe ;
Delaunay, Juliette ;
Mahe, Emmanuel ;
Richard, Marie-Aleth ;
Schoeffler, Amelie ;
Lacour, Jean-Philippe ;
Begon, Edouard ;
Walter-Lepage, Amelie ;
Dillies, Anne-Sophie ;
Rappelle-Duruy, Sandrine ;
Barete, Stephane ;
Bellon, Nathalia ;
Beneton, Nathalie ;
Valois, Aude ;
Barbarot, Sebastien ;
Senechal, Julien ;
Staumont-Salle, Delphine .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :143-151
[10]   The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis [J].
Hanifin, JM ;
Thurston, M ;
Omoto, M ;
Cherill, R ;
Tofte, SJ ;
Graeber, M .
EXPERIMENTAL DERMATOLOGY, 2001, 10 (01) :11-18